Point of Care Testing Market: Current Analysis and Forecast 2019-2025

$3500$6860

Emphasis on Product (Blood Glucose Monitoring Test, Pregnancy & Fertility Testing, Infectious Disease Testing, Cardiac Markers, Anticoagulant Management, Others), Prescription (Near the Patient Testing (NPT), Over the Counter (OCT) /Patient Self-Testing (PST)), End-User (Hospitals, Clinics & Laboratory, Home Setting, Other Health Facilities) and Regions/countries

Pages:

298

Table:

102

Figure:

187

Report ID:

UMHE19195

Geography:

Clear
  Get a Free Sample
SKU: UMHE19195 Category:
Report Description
Table of content
Research Methodology

Report Description

Global Point-of-Care Testing Market (POCT) was valued at US$ 20.42 billion in 2018 and is anticipated to reach US$ 29.27 billion by 2025 displaying a reasonable CAGR of 5.33% over the forecast period (2019-2025). With emerging technological advancements in healthcare, including lab-on-a-chip, smartphone apps, biosensors, and wearable devices that offer a closer connection to the patient point-of-care (POC) technologies are swiftly becoming part of the transformation of the healthcare landscape. The guiding concept in support of Point-of-Care Testing (POCT) is to bring testing closer to the patient. POCT offers more flexibility to meet a diverse range of medical needs because small, portable POCT devices make testing possible in remote locations, such as underserved populations, rural areas, and locations with limited infrastructure or personnel such as disaster, accident, or military sites. The market of POCT is anticipated to grow enormously owing to factors such as rising old age population and age-related diseases, technological advancements. Moreover, development of condition-specific markers and tests and growing significance of Companion Diagnostic will further boost this market. Growing significance of companion diagnostics and investing in unifying technology will further boom the industry and will mark as an upcoming trend. However, stringent government regulations, unfavourable reimbursement policies for POCT and risk of errors would act as the major challenges, but at a low level.

Increasing Prevalence of Chronic Diseases paired with Rising Geriatric (Elderly) Population is the major factor driving the adoption of POCT service. Costly chronic care needs are growing and exerting considerable demand for health systems. Chronic diseases are among the most prevalent and costly health conditions in the United States. Nearly half (approximately 45%, or 133 Million) of all Americans suffer from at least one chronic disease, and the number is growing. Chronic diseases including, cancer, diabetes, hypertension, stroke, heart disease, respiratory diseases, arthritis, obesity, and oral diseases can lead to hospitalization, long-term disability, reduced quality of life, and death. In fact, persistent conditions are the nation’s leading cause of death and disability.

“Amongst POCT product type, blood glucose testing products dominated the market accounting for 75.1% share in 2018”

Based on POCT product, the report segments the market into, Blood Glucose Monitoring Test, Pregnancy & Fertility Testing, Infectious Disease Testing, Cardiac Markers, Anticoagulant Management, Others. Blood Glucose Monitoring Test products dominated the market and is expected to maintain its dominance throughout the forecast period 2019-2025. However, Infectious Disease Testing products are expected to witness the highest CAGR during the analyzed period.

“Over the Counter/Patient Self-Testing (OTC/PST) dominated the market in 2018”

Based on prescription type the global POCT market is segmented into Near the Patient (NPT) and Over the Counter (OTC) /Patient Self-Testing (PST). Over the Counter/Patient Self-Testing (OTC/PST) occupied the largest share and is expected to maintain its dominance throughout the forecast period 2019-2025. Lack of time among the individuals paired with increased disposable income and technological advancement would be the major driving factor for the growth of the segments

  Point-of-Care Testing Market by Prescription, Global, 2018-2025 (US$ Million)

“Hospitals were the major end-user of POCT technology. The segment held 47.7% share in 2018”

On the basis of end-users, the report segments the global POCT market into Hospitals, Clinics & laboratories, home settings and others are the major end-users. In 2018, Hospitals were the largest revenue-generating segment for technology. However, increasing elderly population and associated diseases would drive the increased adoption of POCT for home setting, hence the segment is expected to witness highest CAGR growth of 6.09% during the forecast period 2019-2025.

“North America represents the largest markets for POCT technology globally in 2018, followed by Asia-Pacific and Europe”

For a deep-dive analysis of the overall adoption of POCT technology, detailed analysis was conducted for major regions/countries including North America (US, Canada), Europe (Germany, France, Spain, Italy, UK), Asia-Pacific (China, India, Japan, Australia) and Rest of the world. In 2018, North America dominated the market with ~half the market. However, increasing elderly populations majorly in countries such as Japan and China, Asia-Pacific would emerge as one of the larger markets for the technology in years to come.

Competitive Landscape-Top 10 Market Players

Roche Diagnostics, Becton, Dickinson and Company, Abbott Laboratories, Inc., Biomérieux SA, Bio-Rad Laboratories, Inc., Danaher Corporation, Johnson & Johnson, Siemens Healthineers, Sysmex Corporation and Thermo Fisher Scientific are some of the prominent players operating in the global point-of-care testing market at global scale. However, owing to increasing old age population and rising prevalence age-related disorders, the industry has witnessed emergence of numerous start-ups operating at regional/country level.

Reasons to buy:

  • Current and future market size from 2018 to 2025 in terms of value (US$)
  • Combined analysis of deep-dive secondary research and input from primary research through Key Opinion Leaders of the industry
  • Country-level details of the overall adoption of point of care market along with value chain
  • A quick review of overall industry performance at a glance
  • In-depth analysis of key industry players
  • A detailed analysis of regulatory framework, drivers, restraints, key trends and opportunities, value chain prevailing in the industry
  • Examination of industry attractiveness with the help of Porter’s Five Forces analysis
  • The study comprehensively covers the market across different segments and sub-segments of the technology
  • Region/country Covered: North America (US, Canada and Rest of North America), Europe (UK, Germany, France, Italy, Spain, Rest of Europe), Asia-Pacific (China, India, South Korea, Japan, Australia and Rest of Asia-Pacific), and Rest of the World

Customization Options:

The Global Point-of-Care testing Market can be customized to the country level or any other application. Besides this, UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global POCT Market can be customized to the country level or any other market segment.

You can also purchase parts of this report. Do you want to check out a section wise
price list?

  1.1Market Definition
  1.2Objective of the Study
  1.3Limitation  
  1.4Stakeholders 
  1.5Currency used in the Report
  1.6Scope of the Global Point-of-Care Testing Market Study
  2.1Research Methodology for Global Point-of-Care Testing Market Study
   2.1.1Main objective of the Global Point-of-Care Testing Market Study
  3.1General Overview
  3.2Capturing the full spectrum of the value that a diagnostic test contributes
  3.3Ensuring the Robust Analyses Underpin the Value Assessment
  3.4Accounting for variation in diagnostic test types in value assessment methods
  3.5Aligning on how to Define and Measure Value Drivered
   3.5.1Value Driver: Clinical Impact
   3.5.2Value Driver: Non-Clinical Patient Impact
   3.5.3Value Driver: Care Delivery Revenue and Cost Impact
   3.5.4Value Driver: Public/Population Impact
 4.1General Overview

 

  5.1General Overview
  5.2Introduction and problem statement
   5.2.1Increasing healthcare costs
   5.2.2Underutilization of IVDs in clinical practice
  5.3Consequences for patient care
   5.3.1Conceptual interventions
    5.3.1.1Fostering prevention, screening, early diagnosis, and therapy
    5.3.1.2Promoting comprehensive disease management
    5.3.1.3Promoting Stratified Disease Management
    5.3.1.4Targeted delivery of treatment alongside companion diagnostics
  5.4Consequences for policies: promoting a fee for outcomes
  5.5Analysis of the Study
  5.6Conclusion
  6.1General Overview
  6.2The United States Point-Of-Care Testing Guidelines
   6.2.1Regulations
    6.2.1.1CLIA Waived Status for POCT
   6.2.2Guidelines
    6.2.2.1Obtain Authority to Coordinate Point-of-Care Testing Program
    6.2.2.2Select Members of Point-of-Care Committee (POCC)
    6.2.2.3Committee Develops a Point-of-Care-Program
    6.2.2.4Committee Reviews All Sites for Point-of-Care Testing
    6.2.2.5Evaluation of Proposed Testing
    6.2.2.6Implementation
    6.2.2.7Evaluation of Point-of-Care Testing Program
  6.3Canada Point-of-Care Testing Guidelines
  6.4Australia Point-of-Care Testing Guidelines
  6.5Dubai Point-of-Care Testing Guidelines by Health Regulation Department
   6.5.1Introduction
   6.5.2Professional Requirement
   6.5.3POCT Equipment
   6.5.4Documentation and Transmission of Results
   6.5.5Quality Control
  7.1General Overview
  7.2Supply Chain 
  7.3Risk Assessment
  7.4Bulk, Custom and Contract Manufacturing
  5.1Introduction of Molecular Diagnostics Market
   5.1.1Essential Components or Attributes of Diagnostics
   5.1.2Main Categories of Diagnostics
   5.1.3Settings of Use 
  5.2Current and Future Use of Diagnostic Products
   5.2.1Primary Uses of Diagnostics
    5.2.1.1Predictive Applications/Screening/Early Disease Detection
    5.2.1.2Diagnostic
    5.2.1.3Secondary Risk Assessment – Prognostic
    5.2.1.4Drug Selection/Treatment Targeting
    5.2.1.5Disease/Condition Monitoring and Management
   5.2.2Molecular Diagnostics: Overview of Future Trends and Directions
    5.2.2.1Predict Disease Before Symptoms Appear
    5.2.2.2Predict Beneficial and Adverse Treatment Effects
    5.2.2.3Enable Personalized “Real-Time” Treatment and Disease Management Regimens
    5.2.2.4Facilitate Point-of-care and Near-patient Testing
    5.2.2.5Enable Home Testing
    5.2.2.6Public Health, Environmental, Bioterrorism Applications
    5.2.2.7Technology and Testing System Integration
   5.2.3The Importance of Molecular Diagnostics
   5.2.4Market Drivers 
    5.2.4.1Increasing Prevalence of Chronic Diseases
    5.2.4.2Rising Geriatric Population
    5.2.4.3Increasing adoption of Point-of-Care Diagnosis
    5.2.4.4Technology Advancement in the In-Vitro Diagnostics
    5.2.4.5Advances in Genomics and Proteomics
   5.2.5Market Restraints
    5.2.5.1Unfavorable Reimbursement Policies for In-Vitro Diagnostics
    5.2.5.2High Prices of Molecular Diagnostics Tests
   5.2.6Market Opportunities
    5.2.6.1Increasing Support from Governments and Key Players
    5.2.6.2Growing Significance of Companion Diagnostics
   5.2.7Market Trends 
    5.2.7.1Changing Reimbursement Models and Regulations
    5.2.7.2Investing in Unifying Technology
    5.2.7.3Consolidation and Automation of Labs
    5.2.7.4Shift to Data-Driven Healthcare
    5.2.7.5Consumer Lab Testing
    5.2.7.6Healthcare Convergence
  6.1Regulation  
   6.1.1United States 
    6.1.1.1Approval/Clearance of Molecular Diagnostic Instruments
    6.1.1.2Recommendations for Submissions for Molecular Diagnostic Instruments with Combined Functions
     6.1.1.2.1New Instruments
     6.1.1.2.2Existing Approved/Cleared Instruments
     6.1.1.2.3Submission Information, Labeling, and Marketing
     6.1.1.2.4Promotion and Labeling Issues
     6.1.1.2.5Software/Hardware Changes
     6.1.1.2.6Third-Party Assay Developers
     6.1.1.2.7MDR Reporting
  6.2Reimbursemen
  7.1Demand Side Analysis
   7.1.1Some of the Key Facts about Aging Population
   7.1.2Health Conditions Associated with Aging
    7.1.2.1Some of the key facts about Cardiovascular Diseases (CVD) as per WHO
  7.2Supply Side Analysis 
   7.2.1Product Launches
   7.2.2Partnership 
   7.2.3Business Expansions and Investments
   7.2.4Merger and Acquisition
  7.3SWOT Analysis of Molecular Diagnostics
  7.4Value Chain Analysis of Molecular Diagnostics

 

  10.1Introduction of In-Vitro Diagnostics Market
   10.1.1Comparison of IVD & POCT
   10.1.2Main Categories of Diagnostics
   10.1.3Settings of Use
  10.2The key to accountable adoption of POCT
   10.2.1Drivers of diagnostic technology innovation and adoption:
   10.2.2Current challenges for diagnostic innovation
    10.2.2.1Regulation
    10.2.2.2Evidence generation
    10.2.2.3Clinical needs
    10.2.2.4Commissioning
    10.2.2.5Adoption
   10.2.3Current needs
    10.2.3.1Three key questions for diagnostic innovation:
   10.2.4Developing an evidence ‘toolkit’ for diagnostic test research
  10.3Value of Diagnostics to Health Care and Health Status
  10.4Current and Future Use of Diagnostic Products
   10.4.1Primary Uses of Diagnostics
    10.4.1.1Predictive Applications/Screening/Early Disease Detection
    10.4.1.2Diagnostics
    10.4.1.3Secondary Risk Assessment; Prognostic
    10.4.1.4Drug Selection/Treatment Targeting
    10.4.1.5Disease/Condition Monitoring and Management
   10.4.2In Vitro Diagnostics: Overview of Future Trends and Directions
    10.4.2.1Predict Disease Before Symptoms Appear
    10.4.2.2Predict Beneficial and Adverse Treatment Effects
    10.4.2.3Enable Personalized “Real-Time” Treatment and Disease Management Regimens
    10.4.2.4Facilitate Point-of-care and Near-patient Testing
    10.4.2.5Enable Home Testing
    10.4.2.6Public Health, Environmental, Bioterrorism Applications
    10.4.2.7Technology and Testing System Integration
   10.4.3The importance of Diagnostics in Healthcare
    10.4.3.1The role of diagnostics
    10.4.3.2Improving patient care
    10.4.3.3Reducing healthcare spending
    10.4.3.4Reasons In Vitro Diagnostics Are Superior
  10.5Market Dynamics
   10.5.1Market Drivers
    10.5.1.1Increasing Prevalence of Chronic Diseases
     10.5.1.1.1The Challenges of Chronic Disease
     10.5.1.1.2The Cost of Chronic Diseases
    10.5.1.2Rising Geriatric (Elderly) Population
    10.5.1.3Technology Advancement
   10.5.2Market Restraints
    10.5.2.1Stringent Government Regulations for the Manufacturing of POCT Products
    10.5.2.2Unfavourable Reimbursement Policies for POCT
    10.5.2.3Risk of errors
   10.5.3Market Opportunities
    10.5.3.1Development of Condition-Specific Markers and Tests
    10.5.3.2The growing significance of Companion Diagnostics
   10.5.4Market Trends
    10.5.4.1Changing Reimbursement Models and Regulations
    10.5.4.2Rising Investments in Unifying Technology
    10.5.4.3Consolidation and Automation of Labs
    10.5.4.4Shift towards Data-Driven Healthcare
  11.1Demand  
  11.2Supply Side Analysis
   11.2.1Supply Chain Barriers
    11.2.1.1Product Launch
    11.2.1.2Partnership
    11.2.1.3Business Expansion & Investment
    11.2.1.4Mergers and Acquisitions
   11.2.2Value Chain Analysis of POC Testing
  12.1General Overview
   12.1.1Blood Glucose Monitoring Test
   12.1.2Pregnancy & Fertility Testing
   12.1.3Infectious Disease Testing
   12.1.4Cardiac Markers
   12.1.5Anticoagulant Management
   12.1.6Others
  13.1General Overview
   13.1.1Near the Patient Testing (NPT)
   13.1.2Over the Counter (OCT) /Patient Self-Testing (PST)
  14.1General Overview
   14.1.1Hospitals 
   14.1.2Clinics & Laboratory
   14.1.3Home Setting
   14.1.4Other Health Facilities
  15.1General Overview
  15.2North America POCT Market Insight
   15.2.1North America Point-of-Care Testing Market, By Product
   15.2.2North America Point-of-Care Testing Market by Prescription
   15.2.3North America Point-of-Care Testing Market by End-User
   15.2.4North America POCT Market by Country
    15.2.4.1United States
     15.2.4.1.1Key Findings on Healthcare Spending in the US, 2017
     15.2.4.1.2US Health Spending by Type of Service or Product, 2017
     15.2.4.1.3Health Spending by Major Sources of Funds
     15.2.4.1.4United States Point-of-Care Testing Market, By Product
     15.2.4.1.5United States Point-of-Care Testing Market by Prescription
     15.2.4.1.6United States Point-of-Care Testing Market by End-User
    15.2.4.2Canada
     15.2.4.2.1Key Findings on Canada Healthcare Spending, 2018
     15.2.4.2.2Key Findings on Hospital sector Spending in Canada, 2017
     15.2.4.2.3Canada Point-of-Care Testing Market, By Product
     15.2.4.2.4Canada Point-of-Care Testing Market by Prescription
     15.2.4.2.5Canada Point-of-Care Testing Market by End-User
    15.2.4.3Rest of North America
     15.2.4.3.1Rest of North America Point-of-Care Testing Market, By Product
     15.2.4.3.2Rest of North America Point-of-Care Testing Market by Prescription
     15.2.4.3.3Rest of North America Point-of-Care Testing Market by End-User
  15.3Europe POCT Market Insight
   15.3.1Europe Point-of-Care Testing Market, By Product
   15.3.2Europe Point-of-Care Testing Market by Prescription
   15.3.3Europe Point-of-Care Testing Market by End-User
   15.3.4Europe POCT Market by Country
    15.3.4.1Germany
     15.3.4.1.1Germany Point-of-Care Testing Market, By Product
     15.3.4.1.2Germany Point-of-Care Testing Market by Prescription
     15.3.4.1.3Germany Point-of-Care Testing Market by End-User
    15.3.4.2France
     15.3.4.2.1France Point-of-Care Testing Market, By Product
     15.3.4.2.2France Point-of-Care Testing Market by Prescription
     15.3.4.2.3France Point-of-Care Testing Market by End-User
    15.3.4.3Spain
     15.3.4.3.1Facts on Healthcare Sector Spain
     15.3.4.3.2Spain Point-of-Care Testing Market, By Product
     15.3.4.3.3Spain Point-of-Care Testing Market by Prescription
     15.3.4.3.4Spain Point-of-Care Testing Market by End-User
    15.3.4.4Italy 
     15.3.4.4.1Italy Point-of-Care Testing Market, By Product
     15.3.4.4.2Italy Point-of-Care Testing Market by Prescription
     15.3.4.4.3Italy Point-of-Care Testing Market by End-User
    15.3.4.5United Kingdom
     15.3.4.5.1United Kingdom Point-of-Care Testing Market, By Product
     15.3.4.5.2United Kingdom Point-of-Care Testing Market by Prescription
     15.3.4.5.3United Kingdom Point-of-Care Testing Market by End-User
    15.3.4.6Rest of Europe
     15.3.4.6.1Rest of the Europe Point-of-Care Testing Market, By Product
     15.3.4.6.2Rest of the Europe Point-of-Care Testing Market by Prescription
     15.3.4.6.3Rest of the Europe Point-of-Care Testing Market by End-User
  15.4Asia-Pacific POCT Market Insight
   15.4.1Asia-Pacific Point-of-Care Testing Market, By Product
   15.4.2Asia-Pacific Point-of-Care Testing Market by Prescription
   15.4.3Asia-Pacific Point-of-Care Testing Market by End-User
   15.4.4Asia-Pacific POCT Market by Country
    15.4.4.1China
     15.4.4.1.1Facts on Chinese Elderly Population
     15.4.4.1.2China Point-of-Care Testing Market, By Product
     15.4.4.1.3China Point-of-Care Testing Market by Prescription
     15.4.4.1.4China Point-of-Care Testing Market by End-User
    15.4.4.2India
     15.4.4.2.1India Point-of-Care Testing Market, By Product
     15.4.4.2.2India Point-of-Care Testing Market by Prescription
     15.4.4.2.3India Point-of-Care Testing Market by End-User
    15.4.4.3Japan
     15.4.4.3.1Japan Point-of-Care Testing Market, By Product
     15.4.4.3.2Japan Point-of-Care Testing Market by Prescription
     15.4.4.3.3Japan Point-of-Care Testing Market by End-User
    15.4.4.4Australia
     15.4.4.4.1Australia Point-of-Care Testing Market, By Product
     15.4.4.4.2Australia Point-of-Care Testing Market by Prescription
     15.4.4.4.3Australia Point-of-Care Testing Market by End-User
    15.4.4.5Rest of Asia-Pacific
     15.4.4.5.1Health Expenditure
     15.4.4.5.2Public Hospital Funding – District Health Boards
     15.4.4.5.3Mental Health
     15.4.4.5.4Disability Support Services
     15.4.4.5.5Reduction in costs of visiting GP
     15.4.4.5.6Rest of APAC Point-of-Care Testing Market, By Product
     15.4.4.5.7Rest of APAC Point-of-Care Testing Market by Prescription
     15.4.4.5.8Rest of APAC Point-of-Care Testing Market by End-User
  15.5Rest of World Market Insight
   15.5.1Rest of World Point-of-Care Testing Market, By Product
   15.5.2Rest of the world Point-of-Care Testing Market by Prescription
   15.5.3Rest of the world Point-of-Care Testing Market by End-User
  16.1Porter’s Five forces analysis
   16.1.1Bargaining Power of Suppliers
   16.1.2Bargaining Power of Buyers
   16.1.3Threat of New Entrants
   16.1.4Threat of Substitutes
   16.1.5Industry Rivalry
  16.2Market Share Analysis, by Company
   16.2.1Global Point-of-Care Testing Market Share Analysis, by Company 2018
  17.1Abbott Laboratories
   17.1.1Key Facts 
   17.1.2Business Description
   17.1.3Key Product/Services Offerings
   17.1.4Growth Strategy
   17.1.5SWOT Analysis
   17.1.6Key Financials
    17.1.6.1Revenue Split
   17.1.7Recent Developments
    17.1.7.1Product Launches
    17.1.7.2Partnership
    17.1.7.3Merger and Acquisition
  17.2Becton, Dickinson and Company
   17.2.1Key Facts 
   17.2.2Business Description
   17.2.3Becton Dickinson, and Company, Key Product/Services Offerings
   17.2.4Growth Strategy
   17.2.5SWOT Analysis
   17.2.6Key Financials
    17.2.6.1Revenue Split
   17.2.7Recent Developments
    17.2.7.1Product Launches
    17.2.7.2Business Expansions and Investments
    17.2.7.3Merger & Acquisition
  17.3Biomérieux SA 
   17.3.1Key Facts 
   17.3.2Business Description
   17.3.3Key Product/Services Offerings
   17.3.4Growth Strategy
   17.3.5SWOT Analysis
   17.3.6Key Financials
    17.3.6.1Revenue Split
   17.3.7Recent Developments
    17.3.7.1Product Launches
    17.3.7.2Partnerships
    17.3.7.3Mergers and Acquisitions
  17.4Bio-Rad Laboratories, Inc.
   17.4.1Key Facts 
   17.4.2Business Description
   17.4.3Key Product/Services Offerings
   17.4.4Growth Strategy
   17.4.5SWOT Analysis
   17.4.6Key Financials
    17.4.6.1Revenue Split
   17.4.7Recent Developments
    17.4.7.1Product Launches
    17.4.7.2Mergers and Acquisition
  17.5Danaher Corporation
   17.5.1Key Facts 
   17.5.2Business Description
   17.5.3Key Product/Services Offerings
   17.5.4Growth Strategy
   17.5.5SWOT Analysis
   17.5.6Key Financials
    17.5.6.1Revenue Split
   17.5.7Recent Developments
    17.5.7.1Merger and Acquisitions
  17.6Johnson & Johnson
   17.6.1Key Facts 
   17.6.2Business Description
   17.6.3Key Product/Services Offerings
   17.6.4Growth Strategy
   17.6.5SWOT Analysis
   17.6.6Key Financials
    17.6.6.1Revenue Split
  17.7Roche Holding AG
   17.7.1Key Facts 
   17.7.2Business Description
   17.7.3Key Product/Services Offerings
   17.7.4Growth Strategy
   17.7.5SWOT Analysis
   17.7.6Key Financials
    17.7.6.1Revenue Split
   17.7.7Recent Developments
    17.7.7.1Product Launches
    17.7.7.2Partnership
    17.7.7.3Mergers and Acquisitions
  17.8Siemens Healthineers AG
   17.8.1Key Facts 
   17.8.2Business Description
   17.8.3Key Product/Services Offerings
   17.8.4Growth Strategy
   17.8.5SWOT Analysis
   17.8.6Key Financials
    17.8.6.1Revenue Split
   17.8.7Recent Developments
    17.8.7.1Product Launches
    17.8.7.2Partnerships
    17.8.7.3Business Expansion and Investment
    17.8.7.4Merger and Acquisition
  17.9Thermo Fisher Scientific
   17.9.1Key Facts 
   17.9.2Business Description
   17.9.3Key Product/Services Offerings
   17.9.4Growth Strategy
   17.9.5SWOT Analysis
   17.9.6Key Financials
    17.9.6.1Revenue Split
   17.9.7Recent Developments
    17.9.7.1Product Launches
    17.9.7.2Partnerships
    17.9.7.3Business Expansion and Investments
    17.9.7.4Merger and Acquisition
  17.10Sysmex Corporation
   17.10.1Key Facts 
   17.10.2Business Description
   17.10.3Key Product/Services Offerings
   17.10.4Growth Strategy
   17.10.5SWOT Analysis
   17.10.6Key Financials
    17.10.6.1Revenue Split
   17.10.7Recent Developments
    17.10.7.1Product Launches
    17.10.7.2Partnership
    17.10.7.3Business Expansion & Investments
    17.10.7.4Merger and Acquisition

Research Methodology

Analyzing historical market, estimation of the current market and forecasting the future market for Global POCT market were the three major steps undertaken to create and analyze the overall adoption rate of POCT services in major markets. Exhaustive secondary research was conducted to collect the historical market of the technology and overall estimation of the current market. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were conducted with industry experts across value chain of the POCT technology. Post all the assumptions and validation of market numbers through primary interviews, top-down approach was employed to forecast the complete market size of POCT technology at Global scale. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the overall market size of segments and sub-segments of the technology. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the Global POCT Market through company internal sources such as annual report & financial statements, performance presentations, press releases, inventory records etc. and external sources including trade journals, news & articles, government publications, economic data, competitor publications, sector reports, regulatory bodies publications, safety standard organizations, third-party database and other credible publicationsFor economic data collection, sources such as World Bank, CDC, European Commission (EC), United Nations and WHO, OECD among others were used.

Step 2: Market Segmentation:

Post obtaining the historical market size of the overall market, detailed secondary analysis was conducted to gather historical market insights and share for different segments and sub-segments of the Global POCT service. Major segments included in the report are product, prescription and end-user.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments detailed factor analysis was conducted to estimate the current market size of the Global POCT technology. Factor analysis was conducted using dependent and independent variables such as Accelerating aging population and rising prevalence of age-related disorders, Technology Advancements, etc. Historical trends of the Global POCT and their year-on-year impact on the market size and share in the recent past were analyzed. The demand and supply-side scenario were also thoroughly studied.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at current market size, key players in major applications and markets, market shares of these players and industry’s supply chain. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weightage was assigned to different factors including market dynamics such as drivers, restraints, and trends. After analyzing these factors, relevant forecasting techniques i.e. Bottom-up/Top-down was applied to arrive at the market forecast pertaining to 2025 for different segments and sub-segments in major markets. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of value and rate of adoption of POCT worldwide
  • All percentage shares, splits and breakdowns of market segments and sub-segments
  • Key players in major applications and markets as well as the market share of each player. Also, the growth strategies adopted by these players to compete in the ever-growing Global POCT market

Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, and Regional Head, etc.). Primary research findings were summarized, and statistical analysis was performed to prove the stated hypothesis. Input from primary research was consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants

Market Engineering

Data triangulation technique was employed to complete the overall market engineering process and to arrive at precise statistical numbers of each segment and sub-segment pertaining to the Global POCT market. Data was split into several segments post studying various parameters and trends in the areas of disease testing such as Blood Glucose Monitoring Test, Pregnancy & Fertility Testing, Infectious Disease Testing, Cardiac Markers, Anticoagulant Management and others. A detailed analysis was also conducted for major regions including North America, Europe, Asia-Pacific among others

Main objective of the Global Point-of-Care Testing (POCT) Market Study

The current & future market trends of the global POCT market are pinpointed in the study. The investors can gain strategic insights to base their discretion for investments from the qualitative and quantitative analysis performed in the study. The current and future market trends would determine the overall attractiveness of the market, providing a platform for the diagnostics healthcare participant to exploit the untapped market to benefit as the first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the global  Point-of-Care Testing market in terms of value (US$)
  • Analyze the current and forecast market size of different segments and sub-segments of the market
  • To analyze the revenue and business models of the major market players in the industry along with their growth strategy adopted to sustain in the competitive market
  • To understand the initiatives undertaken by diagnostics companies’ vs service providers to increase the overall analysis of Point-of-Care Testing in major regions
  • Define and describe the segments and sub-segments considered in the evaluation of the global Point-of-Care Testing market and anticipate potential risk associated with the market
  • Define and analysis of the government regulations for diagnostics and point-of-care testing industry
  • Analyze the current and forecast market size of the market for major regions/countries including North America (US, Canada, Rest of North America), Europe (Germany, France, Spain, Italy, UK, Rest of Europe), Asia-Pacific (China, Japan, India, Australia and Rest of Asia-Pacific) and Rest of World
  • Define and analyze the competitive landscape of the global Point-of-Care Testing market and the growth strategies adopted by the market players to sustain in the fast-growing market